| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2009;119:16-18.)
© 2009 American Heart Association, Inc.
Editorial |
From the Department of Neurology (D.W.J.D.) and Thoraxcenter, Department of Cardiology (M.L.S.), Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Correspondence to Diederik W.J. Dippel, MD, PhD, PO Box 2040 3000 CA, The Netherlands. E-mail d.dippel@erasmusmc.nl
Key Words: Editorials stroke guidelines guideline adherence
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Article p 107
Some argue that pursuing adherence to guidelines is a worthy effort by itself, just to bring order into diversity. For others, it seems obvious that use of guidelines leads to improved quality of medical care and improved health outcomes. Yet a few wonder whether the chain of evidence from guideline development and implementation, adherence to guidelines, and improved process of care through improved quality and functional outcomes is everywhere as solid as it should be.
It has become quite clear that in order to improve healthcare quality, merely introducing guidelines is not sufficient, not even after creating a solid framework of evidence-based recommendations. The guidelines should be incorporated in a quality-assurance cycle with education programs and feedback from registries or surveys of clinical practice (Figure 1), such as the Get with the Guidelines program (GWTG).
| |||||||||||
Several large surveys in Europe and the United States have indicated that adherence to guidelines for the clinical management of stroke and cardiovascular disease needs improvement.1,2 For example, treatment with oral anticoagulants
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |